Navigation Links
FDA Clears Medivance's Arctic Sun 5000 for Fastest, Easiest Therapeutic Temperature Management
Date:9/15/2010

LOUISVILLE, Colo., Sept. 15 /PRNewswire/ -- Medivance today announced the introduction of its next-generation therapeutic temperature management device, the non-invasive Arctic Sun® 5000.  The new patient cooling device has received FDA 510 (k) clearance and offers the fastest initiation of treatment, simplest programming capabilities and easiest access to treatment data on the market.

"We beta tested the new device for six months and it's an incredible machine for both therapeutic hypothermia and normothermia indications," said Mary Kay Bader, RN, MSN, CCNS, FAHA of California's Mission Hospital, a nationally renowned cooling expert.  "It's so easy to use and has new functions we find very valuable."

Ms. Bader and others cite the Arctic Sun's pre-programmed protocols and new trend analysis and data collection capabilities as key enhancements that optimize patient care.

"The entire staff loved the Arctic Sun 5000," Bader said.

Favored by hospitals worldwide for its safety, simplicity and precision, the newest Arctic Sun also features:

  • Embedded training
  • The ability to pre-program hospital protocols for rapid induction of temperature control with the push of a button
  • Comprehensive help screen with pop-up explanations for all alerts
  • Voice and visual prompts for added safety
  • Data storage during patient transfers, with ability to "continue current patient case" for up to 6 hours
  • More efficient cooling
  • Touch screen
  • Ability to download up to 10 cases from device memory for research or analysis purposes
  • Automatic initiation of rewarming

"The Arctic Sun 5000 brings precision Targeted Temperature Management™ to the highest level of performance available today," said Medivance CEO Robert Kline.  "With the Arctic Sun 5000 we have made it as effortless as possible to initiate this promising non-invasive therapy that may spare many more critically ill patients from devastating brain damage."

About Medivance's Arctic Sun 5000

The non-invasive Arctic Sun 5000 precisely monitors and maintains core body temperature in a therapeutic range, between 32 and 38.5 degrees Celsius (approximately 89.6 to 101.3 degrees Fahrenheit) with the potential to minimize damage to the heart and brain. The patented design of the Arctic Sun and ArcticGel™ Pads enables them to transfer up to five times more thermal energy than conventional products such as water blankets, wraps or ice packs, resulting in more efficient temperature management. The system's precision also enables the slow rewarming thought to be critical for therapeutic benefit.  The Arctic Sun 5000 has received 510(k) FDA clearance in the U.S. and the European Union's CE Mark.  Medivance develops and manufactures non-invasive, proprietary therapeutic temperature management solutions.   http://www.medivance.com.


'/>"/>
SOURCE Medivance
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Scientist clears hurdles for muscular dystrophy therapy
2. Arctic sea ice thinning at record rate
3. FSU Historians Arctic research has him sitting on top of the world
4. First comprehensive inventory of life in Antarctica
5. ESA satellites focusing on the Arctic
6. Arctic heats up more than other places
7. Global warming threatens Antarctic sea life
8. Marine scientists to assess environment before offshore drilling begins in US arctic waters
9. CO2 drop and global cooling caused Antarctic glacier to form
10. Final frontier: Mission to explore buried ancient Antarctic lake given green light
11. UK robot sub searches for signs of melting 60 km into an Antarctic ice shelf cavity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market Intelligence ... Biometrics and Digital Identity".  Acuity characterizes 2017 as ... when increased adoption reflects a new understanding of ... "Biometrics and digital identity are often perceived ... Maxine Most , Principal of Acuity Market intelligence. ...
(Date:1/23/2017)... , Jan. 23, 2017  The latest mobile ... smartphone prices have dropped dramatically. The quarterly average price ... 2013 to $276 in Q4 2016.  There are now ... price of $116, up from just 28 a year ... According to Maxine Most , Acuity Market ...
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... Calif. , Feb. 17, 2017  Protagonist ... detailing data on its oral peptide drug candidates, ... Congress of the European Crohn,s and Colitis Organization ... Barcelona, Spain from February ... posters detail preclinical data on Protagonist drug candidates ...
(Date:2/16/2017)... Calif. and GREENWICH, Conn. ... a private investment firm focused on venture growth ... the promotion of Josh Richardson , M.D. ... on investments in biotechnology companies.  He is a ... played important roles in Longitude,s investments in Aimmune ...
(Date:2/16/2017)... 16, 2017   Capricor Therapeutics, Inc. ... company developing first-in-class biological therapies for cardiac and ... elected to terminate its license agreement with the ... including Cenderitide. "Our decision to return ... prioritize our efforts to advance our core cell ...
(Date:2/16/2017)... , Feb. 16, 2017  Dermata Therapeutics, ... products to treat a variety of dermatological diseases, ... Series 1a financing and entered into a $5 ...  Dermata intends to use the capital for general ... major advancements in the treatment of serious diseases ...
Breaking Biology Technology: